Add BrightSurf on Google Email

Engineered Salmonella kills tumours. A salt-triggered gel keeps it from poisoning the mice

The study found that a salt-triggered gel containing engineered Salmonella reduced tumour growth by shrinking tumours as well as free bacteria, cutting weight loss by 82% and reversing liver and spleen damage. The gel also delivered the bacteria to the tumours, avoiding poisoning, and showed promise in treating melanoma and other cancers.

SourceInnovation Press·JournalThe Innovation·TypeObservational study·DateNov 11, 2026

Fusion to engineered albumin makes protein-based therapeutics long-acting and gives them the ability to cross mucosal barriers

Researchers developed a long-acting protein-based therapeutic by fusing human erythropoietin to engineered albumin, showing a 5.7-day plasma half-life and improved mucosal barrier crossing. The fusion protein maintained therapeutic function and increased red blood cell production.

SourceUniversity of Oslo, Ullevaal University Hospital·JournalNature Communications·TypeExperimental study·DateOct 28, 2026

Implantable device from MIT researchers uses ultrasound to improve drug delivery to the brain

MIT researchers have designed an implantable drug-delivery device that uses ultrasound to enhance the distribution of drug molecules in the brain. The device, called LUCID, can release drugs over an extended period and bypass the blood-brain barrier, offering a potential way to prevent the recurrence of aggressive brain tumors.

Cancer cells killed with their own carbon monoxide

Researchers at RIKEN have developed a synthetic compound that uses excess carbon monoxide produced by cancer cells to trigger the production of anti-cancer drugs within the cells themselves. The compound selectively targets tumors and avoids harming healthy cells, offering a promising new approach to cancer treatment.

SourceRIKEN·JournalNature Communications·DateOct 22, 2026

Metabolically enhanced pH-dependent conformational switching of polymers for selective chemotherapy of solid tumors

Researchers propose a new approach to targeted chemotherapy, using pH-sensitive polymers to release drugs at acidic tumor sites. The system relies on glucose priming to transiently widen the pH gradient, triggering release from ultra-pH-sensitive carriers. This approach aims to overcome the limitations of current chemotherapy, which of...

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateOct 21, 2026

Batteries that safely break down in the GI tract could improve ingestible devices

Researchers at MIT have created tiny, bioresorbable batteries that can power ingestible electronic devices, such as RFID tags and capsules that stimulate ghrelin production, for up to three days. The batteries, made from magnesium and molybdenum trioxide, can be fully broken down and absorbed by the body, reducing environmental impact.

SourceMassachusetts Institute of Technology·JournalNature Chemical Engineering·DateSep 21, 2026

Bio-Based Fe-MOF nanoreactor builds a redox-cycling strategy for breast cancer therapy

Researchers developed a bio-based Fe-MOF nanoreactor that combines natural-ligand chemistry with multimetallic redox catalysis, biomimetic targeting and MRI visibility. The nanoplatform produced a strong ROS response, increased apoptosis, and tumor inhibition in breast cancer cells and mice.

SourceJournal of Bioresources and Bioproducts·JournalJournal of Bioresources and Bioproducts·TypeExperimental study·DateSep 3, 2026

NTU Singapore scientists develop microdroplets that can reduce colorectal tumor growth at potentially lower cost

NTU Singapore scientists have developed microdroplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing colorectal tumor growth by 67% in mice. The approach targets two proteins that cancer cells exploit to evade immune attacks, and could potentially cost 5-10 times less to produce than curre...

SourceNanyang Technological University·JournalBiomaterials·TypeExperimental study·DateSep 3, 2026

Pusan National University develops injectable microgels for targeted keloid radiotherapy

Researchers from Pusan National University developed an injectable system to deliver radiation directly within keloid tissue, providing a minimally invasive approach to treat abnormal scars. The microgels enabled rapid and efficient radiolabeling, and therapeutic efficacy was demonstrated in mice carrying patient-derived keloid tissue.

SourcePusan National University·JournalJournal of Controlled Release·TypeExperimental study·DateAug 27, 2026

Rethinking oral cancer treatment: A review of next-generation drug delivery systems

Researchers emphasize the need for personalized drug delivery systems that consider tumor biology, location, and patient factors to effectively treat oral cancer. Mucoadhesive films, oral sprays, and injectable hydrogels are promising technologies, but their translation to clinical use depends on practical considerations.

SourceHasanuddin University·JournalEuropean Journal of Pharmaceutics and Biopharmaceutics·TypeLiterature review·DateAug 26, 2026

‘Switchable’ smart gel may pave way for next-gen drug delivery and sensing tech

Scientists create a new material that changes from a gel to a liquid-like state under ultraviolet light, and can be rebuilt using heat or dismantled by acid. The discovery could lead to the design of smart sensors, switchable catalysts, and materials that capture and release selected molecules on demand.

SourceUniversity of Birmingham·JournalJournal of the American Chemical Society·TypeExperimental study·DateAug 18, 2026

Hebei Medical University researchers review prolonged disorders of consciousness management

Researchers from Hebei Medical University review current evidence on prolonged disorders of consciousness (pDOC) management. They propose a brain communication network model to explain how brain injury leads to long-term unconsciousness, identifying key brain electrical signaling activity measures for diagnosis and treatment.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateAug 17, 2026

Chinese Neurosurgical Journal reviews explore blood–brain barrier-aware nanomedicines for glioblastoma

Recent research explores the use of nanomaterial-based drug delivery to increase treatment efficacy for glioblastoma, a type of brain tumor with poor prognosis. Stimuli-responsive and biomimetic nanomedicines are designed to overcome the blood–brain barrier and deliver drugs selectively within tumors.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateAug 12, 2026

Endocytosis-independent delivery: Bypassing cellular barriers for direct biomolecule translocation into living cells

Emerging non-endocytic delivery strategies enable direct cytosolic delivery of proteins, nucleic acids, and gene-editing tools, providing new opportunities for biomedical therapies. The review discusses their application prospects in gene therapy, macromolecular drug delivery, and cellular engineering.

SourceBiomedical Analysis·JournalBiomedical Analysis·TypeLiterature review·DateJul 24, 2026

Enlisting pharmacists and nurse practitioners in medication management can fill critical gaps in heart failure care, save lives, and reduce hospital stays

Expanding heart failure care to pharmacists and nurse practitioner-led medication management can save approximately 10 lives and prevent 25 hospitalizations per 1,000 patients. This service is estimated to be cost-effective and improve patient outcomes, providing a roadmap for a stronger healthcare system.

SourceElsevier·JournalCanadian Journal of Cardiology·TypeComputational simulation/modeling·DateJun 29, 2026

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S.

A recent study found that the FDA approval of semaglutide for weight management led to a significant increase in calls to poison control centers, with over 8,000 cases reported by 2023. The majority of errors were preventable and stemmed from unintentional dosing or therapeutic mistakes.

SourceUniversity of Texas at San Antonio·JournalJournal of Medical Toxicology·DateJun 23, 2026

Polyoxometalate-driven interfacial assembly enables functional mesoporous polydopamine nanomotors

Researchers developed anisotropy-tunable mesoporous polydopamine nanomotors with POM-mediated assembly, which combine intrinsic antibacterial activity, self-propulsion, and high drug-loading capacity. These nanomotors demonstrate enhanced antibacterial efficiency and biofilm eradication against drug-resistant bacterial biofilms.

SourceScience China Press·JournalNational Science Review·TypeExperimental study·DateJun 8, 2026

UMass Amherst researchers combine bacteria and viruses to demonstrate a new way to fight cancer

Researchers at UMass Amherst have designed a new therapy that combines engineered Salmonella bacteria with oncolytic viruses to target liver and pancreatic cancer. The treatment showed promising results in animal models, leading to significant tumor reduction and improved survival rates.

SourceUniversity of Massachusetts Amherst·JournalCell Reports Medicine·TypeRandomized controlled/clinical trial·DateJun 3, 2026

DNA ‘barcodes’ help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source

The study uses DNA barcodes to track and compare dozens of gold nanoparticle designs in living tumour models, identifying those effective at reaching mitochondria. Two formulations emerged as standout performers, achieving high tumour regression when combined with RNA therapy and photothermal treatment.

SourceNational University of Singapore·JournalAdvanced Materials·DateMay 11, 2026

UH professor urges better prevention and care of liver disease to reduce burden

Chronic liver disease in the US costs $41.57 billion, with prescription medication expenditures accounting for nearly half of all-cause healthcare expenditures. Poor adherence to antiviral medications is a key factor in preventing disease progression and treatment, with high out-of-pocket costs increasing non-adherence risk.

SourceUniversity of Houston·JournalExpert Review of Pharmacoeconomics & Outcomes Research·DateApr 28, 2026

Scientists reverse brain aging, with a nasal spray

Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.

SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026

Surface charge and membrane lipid composition define extracellular vesicle (EV) function: Lipid asymmetry enables new quality metrics for EV-based therapeutics

A comprehensive review reveals how phospholipid asymmetry governs EV surface charge, providing a unified framework for classification, functional understanding, and standardization in nanomedicine. The study highlights the importance of membrane lipid composition and surface charge in determining EV function.

SourceInnovation Center of NanoMedicine·JournalACS Nano Medicine·TypeSystematic review·DateApr 14, 2026

Terasaki principal investigator Dr. Yangzhi Zhu publishes smart contact lens for real-time IOP monitoring and closed-loop treatment delivery in Science Translational Medicine

Researchers at Terasaki Institute for Biomedical Innovation develop a smart contact lens that monitors intraocular pressure in real time and delivers treatment. The technology has shown promising results in preclinical models and aims to improve quality of life for patients with ocular diseases.

SourceTerasaki Institute for Biomedical Innovation·JournalScience Translational Medicine·TypeExperimental study·DateApr 8, 2026